Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. 04/11/2025: Brief amicus curiae of Washington ... 05/12/2025: Brief of respondents Doris Albrecht, et al. in ...

Pharmaceutical company, Merck is closing a Pennsylvania plant. Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck ...

Merck sued Azurity Pharmaceuticals Inc. on May 3 in Delaware District Court over patent infringement claims. The court action, brought by McCarter & English and Williams & Connolly, asserts a ...

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. March 20, 2025 at 12:00 AM. Email. Share. Print. Case Digest Summary. Defendants appealed the ruling affirming United States Patent and ...

Merck Sharp & Dohme LLC and Otsuka Pharmaceutical Co. Ltd. have patented cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the treatment of cancer.

A Merck Sharp & Dohme Corp patent related to its diabetes drugs Januvia and Janumet is valid, a U.S. appeals court said Thursday, rejecting a challenge to the patent by generic drugmaker Mylan ...

VGX-3100: Inovio Pharmaceuticals. ... Merck sharp & Dohme Key Products. VGX-3100 Artesunate ABI-2280 GX-188E Pembrolizumab ...

MERCK SHARP & DOHME LLC's most active month to dispose stocks was the month of July. In 2007 MERCK SHARP & DOHME LLC cashed out on 3,206,318 shares for a total of $86,282,017.38 , their largest ...

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Sezary Syndrome - Pipeline Insights, 2024" has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 5 ...

Cherokee Pharmaceuticals, a wholly owned subsidiary of Merck Sharp & Dohme, which is a wholly owned subsidiary of Merck & Co., has filed a Worker Adjustment and Retraining Notification with the ...